|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Internal Medicine, The Ohio State University, Columbus, Ohio, United States
2 Surgery, The Ohio State University, Columbus, Ohio, United States
3 United States; Internal Medicine, The Ohio State University, Columbus, Ohio, United States
* To whom correspondence should be addressed. E-mail: kuppusamy.1{at}osu.edu.
It is unclear whether oxygen plays a role in stem-cell therapy. Hence the determination of local oxygenation (pO2) in the infarct heart and at the site of transplantation may be critical to study the efficacy of cell therapy. To demonstrate this, we have developed an oxygen-sensing paramagnetic spin probes (OxySpin) to monitor oxygenation in the region of cell transplantation using electron paramagnetic resonance (EPR) spectroscopy. Skeletal myoblast (SM) cells isolated from thigh muscle biopsies of mice were labeled with OxySpin by co-culturing the cells with submicron-sized (270±120 nm) particulates of the probe. Myocardial infarction was created by left coronary artery ligation in mice. Immediately after ligation, labeled SM cells were transplanted in the ischemic region of the heart. The engraftment of the transplanted cells and in situ pO2 in the heart were monitored weekly for four weeks. EPR measurements revealed the retention of cells in the infarcted tissue. The myocardial pO2 at the site of SM cell therapy was significantly higher compared with the untreated group throughout the 4-week period. Histological studies revealed differentiation and engraftment of SM cells into myotubes and increased incidence of neovascularization in the infarct region. The infarct size in the treated group was significantly decreased while echocardiography showed an overall improvement in cardiac function when compared to untreated hearts. To our knowledge, this the first report detailing changes in in situ oxygenation in cell therapy. The increased myocardial pO2 positively correlated with neoangiogenesis and cardiac function.
This article has been cited by other articles:
![]() |
S. Wisel, M. Khan, M. L. Kuppusamy, I. K. Mohan, S. M. Chacko, B. K. Rivera, B. C. Sun, K. Hideg, and P. Kuppusamy Pharmacological Preconditioning of Mesenchymal Stem Cells with Trimetazidine (1-[2,3,4-Trimethoxybenzyl]piperazine) Protects Hypoxic Cells against Oxidative Stress and Enhances Recovery of Myocardial Function in Infarcted Heart through Bcl-2 Expression J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 543 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Chacko, M. Khan, M. L. Kuppusamy, R. P. Pandian, S. Varadharaj, K. Selvendiran, A. Bratasz, B. K. Rivera, and P. Kuppusamy Myocardial oxygenation and functional recovery in infarct rat hearts transplanted with mesenchymal stem cells Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1263 - H1273. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kaushal, C. P. Bouchard, and L. E. Wold Myocardial oxygenation is critical for improving regeneration capacity Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1215 - H1216. [Full Text] [PDF] |
||||
![]() |
I. K. Mohan, M. Khan, S. Wisel, K. Selvendiran, A. Sridhar, C. A. Carnes, B. Bognar, T. Kalai, K. Hideg, and P. Kuppusamy Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H140 - H151. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |